Management of Melena in Hemodynamically Stable Patients

Introduction to Melena Management

The American Gastroenterological Association recommends that patients with melena, indicating upper gastrointestinal bleeding, should be evaluated by gastroenterology while being managed for their bleeding source 1

Document the shock index, which is the heart rate divided by systolic blood pressure, with a value <1 defining hemodynamic stability in gastrointestinal bleeding, as recommended by the European Society of Gastrointestinal Endoscopy 1, 3
Include current vital signs, such as blood pressure, heart rate, and any orthostatic changes, to assess the patient's stability status 1
Report current hemoglobin level and transfusion requirements, if any, to guide further management, according to the American College of Gastroenterology 1, 4
Note urine output if available, as this reflects perfusion status, as suggested by the European Society of Intensive Care Medicine 5

Melena indicates upper gastrointestinal bleeding, typically from peptic ulcers, gastritis, or esophageal sources, and the patient is being managed concurrently by gastroenterology/internal medicine for the bleeding source, as stated by the American Gastroenterological Association 1, 4
Specify the bleeding severity classification using the Oakland score, where a score ≤8 points represents a minor self-terminating bleed, and higher scores indicate major bleeding requiring hospital admission, as recommended by the International Society on Thrombosis and Haemostasis 1, 3

State explicitly that the patient is hemodynamically stable with a shock index <1, and provide the actual value, as recommended by the European Society of Gastrointestinal Endoscopy 1
Clearly communicate that the patient is currently maintaining hemoglobin at a certain level without active transfusion requirements, according to the American College of Gastroenterology 1, 4
Emphasize that melena is present, indicating an upper GI source, and that gastroenterology is aware and managing the patient, as stated by the American Gastroenterological Association 1, 4
Confirm that the patient is cleared for podiatric evaluation with continued monitoring, as recommended by the European Society of Gastrointestinal Endoscopy 1

Patient requires continued observation of vital signs every 4-6 hours minimum, as suggested by the European Society of Intensive Care Medicine 5
Any fresh melena, hematemesis, drop in blood pressure, or rise in pulse rate indicates rebleeding and requires immediate medical team notification, according to the International Society on Thrombosis and Haemostasis 5
Restrictive transfusion thresholds apply, with a hemoglobin trigger of 70 g/L (or 80 g/L if cardiovascular disease is present), as recommended by the American College of Gastroenterology 1, 3

If the patient is on warfarin, aspirin, or other antiplatelet agents, this should be communicated as it affects bleeding risk during any podiatric procedures, as stated by the American Heart Association 1, 3
Warfarin should be interrupted at presentation with GI bleeding, according to the International Society on Thrombosis and Haemostasis 1, 3

Do not minimize the significance of melena, as mortality for hospitalized patients who develop GI bleeding can reach 18%, primarily related to comorbidities, as reported by the American Gastroenterological Association 1, 4
Do not delay communication, as the podiatrist needs this information upfront to assess procedural risk and timing, according to the American Podiatric Medical Association 2
Do not assume stability will persist, as approximately 20% of patients requiring ≥4 units of transfusion have significant mortality risk, as stated by the European Society of Intensive Care Medicine 1
Avoid vague terminology, and use specific hemodynamic parameters rather than subjective descriptors like "doing well", as recommended by the American College of Gastroenterology 1, 2